Physician

Huy V. Nguyen, MD

According to 2025 Medicare claims, Huy Nguyen, MD (NPI: 1770659252) practices hematology/oncology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is SUTTER BAY MEDICAL FOUNDATION (NPI: 1013950807; TIN: 941156581) and primary practice location at 94086-6386. Nguyen is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Nguyen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 714 traditional Medicare patients, billed 120,120 HCPCS/CPT codes, and received $2,135,811 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,310 prescription claims across 210 beneficiaries totaling $3,532,202 in drug costs, led by Revlimid (Lenalidomide). DME data shows 12 claims. Open Payments data shows 7 records totaling $374. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $33,320 to $2,135,811. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,039,016 and ending at $3,532,202. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	26	1,277	$33,320
2016	27	1,831	$17,401
2017	29	3,852	$49,626
2018	34	4,913	$84,562
2019	352	38,988	$704,254
2020	478	72,732	$1,242,775
2021	533	95,205	$1,696,450
2022	637	93,190	$1,698,555
2023	632	101,062	$1,667,735
2024	714	120,120	$2,135,811

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	160	836	$2,039,016
2016	198	1,256	$3,250,663
2017	181	1,210	$3,501,606
2018	209	1,297	$4,515,042
2019	192	765	$1,897,610
2020	94	478	$745,787
2021	100	621	$965,502
2022	123	732	$1,937,114
2023	175	882	$2,061,972
2024	210	1,310	$3,532,202

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	36	$3,851
2021	N/R	29	$1,174
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$226

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	192	562	$168
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	173	227	$114
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	115	202	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	196	323	$15
J7050	Infusion, normal saline solution, 250 cc	148	225	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	30	840	$572,716
Xtandi	Enzalutamide	31	930	$438,244
Brukinsa	Zanubrutinib	29	870	$437,176
Tagrisso	Osimertinib Mesylate	21	630	$347,530
Tasigna	Nilotinib Hcl	12	336	$227,158

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$374	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Huy V. Nguyen, MD?

Tedicare shows public-source Medicare data for Huy V. Nguyen, MD (NPI 1770659252), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Huy V. Nguyen, MD have ACO affiliation data?

Huy V. Nguyen, MD is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Huy V. Nguyen, MD?

Huy V. Nguyen, MD is linked to SUTTER BAY MEDICAL FOUNDATION (billing NPI 1013950807) in the available physician profile data.

Does Huy V. Nguyen, MD have Open Payments data?

Huy V. Nguyen, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.